Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

February 16, 2022

JANSSEN PHARMACEUTICALS, INC. et al v. ACCORD HEALTHCARE, INC.

Track this case

Case Number:

2:22-cv-00856

Court:

New Jersey

Nature of Suit:

Patent - Abbreviated New Drug Application(ANDA)

Judge:

Claire C. Cecchi

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. February 17, 2022

    J&J Units Aim To Hit Brakes On Generic Schizophrenia Drug

    Johnson & Johnson units have slammed Intas Pharmaceuticals Ltd. with a patent suit in New Jersey federal court seeking to block the India-based drugmaker from selling a generic version of the schizophrenia drug Invega Sustenna, saying the sales would infringe the asserted claims of a patent covering the drug.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login